193 related articles for article (PubMed ID: 27384479)
1. Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.
Chen SJ; Kuo CC; Pan HY; Tsou TC; Yeh SC; Chang JY
Oncotarget; 2016 Aug; 7(31):49310-49321. PubMed ID: 27384479
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.
Chen SJ; Kuo CC; Pan HY; Tsou TC; Yeh SC; Chang JY
Biochem Pharmacol; 2015 May; 95(1):28-37. PubMed ID: 25801007
[TBL] [Abstract][Full Text] [Related]
3. Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity.
Cui H; Zhang AJ; McKeage MJ; Nott LM; Geraghty D; Guven N; Liu JJ
J Inorg Biochem; 2017 Dec; 177():249-258. PubMed ID: 28551160
[TBL] [Abstract][Full Text] [Related]
4. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
[TBL] [Abstract][Full Text] [Related]
5. Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy.
Chen HH; Chen WC; Liang ZD; Tsai WB; Long Y; Aiba I; Fu S; Broaddus R; Liu J; Feun LG; Savaraj N; Kuo MT
Expert Opin Ther Targets; 2015; 19(10):1307-17. PubMed ID: 26004625
[TBL] [Abstract][Full Text] [Related]
6. Overcoming platinum drug resistance with copper-lowering agents.
Chen HH; Kuo MT
Anticancer Res; 2013 Oct; 33(10):4157-61. PubMed ID: 24122978
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic basis for overcoming platinum resistance using copper chelating agents.
Liang ZD; Long Y; Tsai WB; Fu S; Kurzrock R; Gagea-Iurascu M; Zhang F; Chen HH; Hennessy BT; Mills GB; Savaraj N; Kuo MT
Mol Cancer Ther; 2012 Nov; 11(11):2483-94. PubMed ID: 22914438
[TBL] [Abstract][Full Text] [Related]
8. Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis.
Lai YH; Kuo C; Kuo MT; Chen HHW
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772714
[TBL] [Abstract][Full Text] [Related]
9. Tumors established with cell lines selected for oxaliplatin resistance respond to oxaliplatin if combined with cetuximab.
Prewett M; Deevi DS; Bassi R; Fan F; Ellis LM; Hicklin DJ; Tonra JR
Clin Cancer Res; 2007 Dec; 13(24):7432-40. PubMed ID: 18094427
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
[TBL] [Abstract][Full Text] [Related]
11. Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy.
Kuo MT; Fu S; Savaraj N; Chen HH
Cancer Res; 2012 Sep; 72(18):4616-21. PubMed ID: 22962276
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals.
Liang ZD; Long Y; Chen HH; Savaraj N; Kuo MT
J Biol Inorg Chem; 2014 Jan; 19(1):17-27. PubMed ID: 24132751
[TBL] [Abstract][Full Text] [Related]
13. Specificity protein 1 (sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression.
Liang ZD; Tsai WB; Lee MY; Savaraj N; Kuo MT
Mol Pharmacol; 2012 Mar; 81(3):455-64. PubMed ID: 22172574
[TBL] [Abstract][Full Text] [Related]
14. Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.
Chen CC; Chen LT; Tsou TC; Pan WY; Kuo CC; Liu JF; Yeh SC; Tsai FY; Hsieh HP; Chang JY
Br J Cancer; 2007 Aug; 97(3):334-44. PubMed ID: 17609664
[TBL] [Abstract][Full Text] [Related]
15. β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.
Li X; Lin Z; Zhang B; Guo L; Liu S; Li H; Zhang J; Ye Q
Sci Rep; 2016 Feb; 6():21010. PubMed ID: 26867799
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells.
Song IS; Chen HH; Aiba I; Hossain A; Liang ZD; Klomp LW; Kuo MT
Mol Pharmacol; 2008 Sep; 74(3):705-13. PubMed ID: 18483225
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters.
Guo Y; Smith K; Petris MJ
J Biol Chem; 2004 Nov; 279(45):46393-9. PubMed ID: 15326162
[TBL] [Abstract][Full Text] [Related]
18. Effects of Cu(II) and cisplatin on the stability of Specific protein 1 (Sp1)-DNA binding: Insights into the regulation of copper homeostasis and platinum drug transport.
Yan D; Aiba I; Chen HH; Kuo MT
J Inorg Biochem; 2016 Aug; 161():37-9. PubMed ID: 27172866
[TBL] [Abstract][Full Text] [Related]
19. Platinum transfer from hCTR1 to Atox1 is dependent on the type of platinum complex.
Wu X; Yuan S; Wang E; Tong Y; Ma G; Wei K; Liu Y
Metallomics; 2017 May; 9(5):546-555. PubMed ID: 28383086
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice.
Okazaki F; Matsunaga N; Okazaki H; Utoguchi N; Suzuki R; Maruyama K; Koyanagi S; Ohdo S
Cancer Res; 2010 Aug; 70(15):6238-46. PubMed ID: 20631077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
